A recent study highlights the effectiveness of adding a minimally invasive laser procedure to immunotherapy, significantly improving survival rates for patients with recurrent high-grade astrocytoma, ...

Learn how a new laser-based therapy is giving patients with aggressive brain cancer a stronger chance at survival.

A project at Keck Medicine of USC has developed a laser-based treatment that may dramatically improve survival for patients with brain cancer. Published in Nature Communications the findings offer ...

High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients with recurrent ...

Keck Medicine of USC researchers have reported striking early results from a clinical trial that could reshape treatment for one of the deadliest brain cancers.

A new study shows that combining laser treatment with immunotherapy significantly improves survival rates in patients with ...

A clinical trial shows that combining laser heat therapy with immunotherapy significantly extends the lives of patients with aggressive, recurrent brain cancer.

FOLFIRI plus bevacizumab (B) as neoadjuvant treatment for potentially resectable colorectal cancer patients (pts) with liver metastasis: A phase II trial. This is an ASCO Meeting Abstract from the ...